CA Patent

CA1247547A — Leucine derivatives

Assigned to F Hoffmann La Roche AG · Expires 1988-12-28 · 37y expired

What this patent protects

Abstract The novel compounds of the general formula I wherein A signifies the group or -(CH2)5-, inhibit pancreas lipase and can be used for the control or prevention of obesity and hyperlipaemia.

USPTO Abstract

Abstract The novel compounds of the general formula I wherein A signifies the group or -(CH2)5-, inhibit pancreas lipase and can be used for the control or prevention of obesity and hyperlipaemia.

Drugs covered by this patent

Patent Metadata

Patent number
CA1247547A
Jurisdiction
CA
Classification
—
Expires
1988-12-28
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.